Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Allander Biotechnologies LLC
Profile last edited on: 1/12/2018      CAGE: 7LHX9      UEI: J8KMX54WRJM9

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2014
First Award
2014
Latest Award
2021
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

12635 East Montview Boulevard Suite 100
Aurora, CO 80045
   (303) 724-3001
   N/A
   N/A
Location: Single
Congr. District: 06
County: Adams

Public Profile

Allander Biotechnologies is a start-up company organized around development of proprietary biologics to improve wound healing and treat scar, fibrotic and inflammatory disorders. The current SBIR Phase II (NIH FY 17) was transferred from another SBIR-involved firm - a not common occurence when it involved change inthe PI and research team

Extent of SBIR involvement

User Avatar
Phase I Awards
3
Phase II Awards
3
Conversion Rate
100.00%
Phase I Dollars
$381,002
Phase II Dollars
$4,691,949
Total Awarded
$5,072,951

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2023 2 NIH $2,926,078
Project Title: SMAD7 Use in Oral Mucositis Treatment
2021 2 NIH $1,680,880
Project Title: Proprietary Drug to Treat Radiodermatitis
2019 2 NIH $1,705,741
Project Title: Testing SMAD7-Based Biologics for Treating Chronic Wounds

Key People / Management

  Xiao-Jing Wang

  Christian Young

Company News

There are no news available.